<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01973777</url>
  </required_header>
  <id_info>
    <org_study_id>130928 IUB</org_study_id>
    <nct_id>NCT01973777</nct_id>
  </id_info>
  <brief_title>A Pilot Study of Early Expulsion Rates of the IUB™ SCu380A</brief_title>
  <acronym>IUB</acronym>
  <official_title>A Pilot Study of Early Expulsion Rates of the IUB™ SCu380A Spherical Copper Intrauterine Contraceptive Device.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wiebe, Ellen, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wiebe, Ellen, M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The IUB (Intrauterine ball) is a copper releasing intrauterine contraceptive device
      consisting of copper beads on a flexible NiTinol wire. It was designed to reduce the pain and
      bleeding caused by traditional T-shaped copper IUDs and to reduce expulsions. In an initial
      pilot of 15 women, there were no complications during the 12 months. This observational pilot
      study of 50 women will determine that the early expulsion rate is not greater than 10% and
      that there is patient and physician acceptance, so that we can plan a larger randomized
      controlled trial for efficacy and safety.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2013</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>intrauterine contraceptive device IUB</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Expulsion Rate</measure>
    <time_frame>at 6-8 weeks</time_frame>
    <description>The device being expelled from the uterus as documented by ultrasound or by seeing the actual device outside the uterus</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complication</measure>
    <time_frame>12 months</time_frame>
    <description>infection, perforation, pregnancy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability</measure>
    <time_frame>12 months</time_frame>
    <description>patient-reported acceptability</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>IUB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There is one arm of women who will have IUBs inserted</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IUB</intervention_name>
    <description>intrauterine contraceptive device</description>
    <arm_group_label>IUB</arm_group_label>
    <other_name>SCu380A IUB™</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  requesting non-hormonal intrauterine contraception

          -  able to return for ultrasound in 6-8 weeks

        Exclusion Criteria:

          -  History of recent pelvic inflammatory disease

          -  Known anemia

          -  Dysfunctional uterine bleeding

          -  Malignancy or suspected malignant disease of female inner or outer genitalia

          -  Known intolerance or allergy to copper and/or copper IUDs

          -  Any other significant disease or condition that could interfere with the subject's
             ability to complete the protocol

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Willow Women's Clinic</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z1H9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2013</study_first_submitted>
  <study_first_submitted_qc>October 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2013</study_first_posted>
  <results_first_submitted>December 31, 2015</results_first_submitted>
  <results_first_submitted_qc>December 31, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 2, 2016</results_first_posted>
  <last_update_submitted>March 26, 2017</last_update_submitted>
  <last_update_submitted_qc>March 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intrauterine device, contraception</keyword>
  <study_docs>
    <study_doc>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>http://www.contraceptionjournal.org/article/S0010-7824%2815%2930125-6/abstract</doc_url>
    </study_doc>
  </study_docs>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>IUB Inserted</title>
          <description>There is one arm of women who will have IUBs inserted
IUB: intrauterine contraceptive device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51">January 2014</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>One Year Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IUB Inserted</title>
          <description>There is one arm of women who will have IUBs inserted
IUB: intrauterine contraceptive device</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27" lower_limit="18" upper_limit="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Expulsion Rate</title>
        <description>The device being expelled from the uterus as documented by ultrasound or by seeing the actual device outside the uterus</description>
        <time_frame>at 6-8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IUB Inserted</title>
            <description>There is one arm of women who will have IUBs inserted
IUB: intrauterine contraceptive device</description>
          </group>
        </group_list>
        <measure>
          <title>Expulsion Rate</title>
          <description>The device being expelled from the uterus as documented by ultrasound or by seeing the actual device outside the uterus</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Complication</title>
        <description>infection, perforation, pregnancy</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IUB Inserted</title>
            <description>There is one arm of women who will have IUBs inserted
IUB: intrauterine contraceptive device</description>
          </group>
        </group_list>
        <measure>
          <title>Complication</title>
          <description>infection, perforation, pregnancy</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Acceptability</title>
        <description>patient-reported acceptability</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IUB Inserted</title>
            <description>There is one arm of women who will have IUBs inserted
IUB: intrauterine contraceptive device</description>
          </group>
        </group_list>
        <measure>
          <title>Acceptability</title>
          <description>patient-reported acceptability</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>IUB Inserted</title>
          <description>There is one arm of women who will have IUBs inserted
IUB: intrauterine contraceptive device</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>expulsions</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Ellen Wiebe</name_or_title>
      <organization>University of British Columbia</organization>
      <phone>6047095611</phone>
      <email>ellenwiebe@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

